Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19

Khunti, Kamlesh; Ruan, Yue; Davies, Jim; Field, Benjamin C.T.; Harris, Sophie; Kosiborod, Mikhail; Nagi, Dinesh; Narendran, Parth; Patel, Dipesh; Ryder, Robert E.J.; Várnai, Kinga A.; Wild, Sarah H.; Wilmot, Emma G.; Rea, Rustam; Gandhi, Rajiv; Harris, Sophie; Nagi, Dinesh; Ryder, Robert; Davies, Jim; Harris, Steve; Freeman, Oliver; Maylor, Ben; Várnai, Kinga A.; Roadknight, Gail; Cull, Melissa; Ruan, Yue; Edwards, Amy; Gelding, Susan; Gunganah, Kirun; Aung, Pyei; Banerjee, Moulinath; Chakera, Ali; Rouse, Dominique; Ahmed, Syed Haris; Cheung, Ho Yee; Roberts, Hywel; Seal, Susan; Shah, Syed Saah; Hayat, Amir; Mohandas, Cynthia; Aung, Htet Htet; Chel, Su Khant; Lin, Nyan; Narula, Kavitia; Quadri, Furruq; Yin, Su Lei; Yin, Yin; Alkundi, Alamin; Musa, Abdelmajid; Birbeck, Emma; Bodmer, Charles; Bossman, Irene; Kumar, Sathis; Dashora, Umesh; Toubi, Elizabeth; Zafar, Mansoor; Patel, Vinod; Gopinath, Amitha; Allan, Belinda; Karim, Remat; Appuhamillage, Dharshana; Ayoub, Khubaib; Ilangaratne, Charmaine; Iqbal, Maliha; Maclean, Rory; Mustafa, Omar; Baxter, Susan; Adamus, Malgorzata; Baynes, Kevin; Sivappriyan, Siva; D’Costa, Ryan; Parfitt, Vernon; Islam, Mazharul; Nasir, Sadia; Várnai, Kinga; Vasan, Senthil; Devah, Vilashini Arul; Kavvoura, Foteini; Ficken, Lina; Gilham, James; Simpson, Vincent; Walker, Neil; Aziz, Umaira; Karra, Efthimia; Rosenthal, Miranda; Curran, Tracy; Paisley, Angela; De P, Parijat; Sarkar, Priscilla; Clark, James; Hogan, Vesna; Jackson, Lauren; Williamson, Jamie-Leigh; Younes, R.; Robin, Lucy; Grixti, Lydia; Tee, Suann; Sathya, Abilash; Patel, Mayank; Holmes, Catherine; Hanif, Wasim; Ghosh, Sandip; Ahmad, Ehtasham; Ahmed, Ejaz; Davies, Melanie; Hartshorn, Steven; Simons, Lee; Webb, David; Brahm, Anupam; Pramodh, Seshadri; Frew, Katy; Mackenzie, Alison; Wild, Abigail; Casey, Helen; Morrison, Deborah; McKeag, Conor; Sillars, Anne; Stirling, Angus; Smeeton, Fiona; Muhammad, Syed; Obuobie, Kofi; Yin, Win; Agarwal, Neera; Atkinson, Mike; Ambati, Sai; Khan, Rahim; Nalla, Preethi; Tabasum, Arshiya; Zouras, Stamatios; Mallipedhi, Akhila; Chudleigh, Richard; Williams, David

doi:10.2337/dc22-0357

All Outputs (2)

A nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID‐19 (2023)
Journal Article

Aims To investigate characteristics of people hospitalized with coronavirus-disease-2019 (COVID-19) and diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS), and to identify risk factors for mortality and intensive care admission... Read More about A nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID‐19.

Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19 (2022)
Journal Article

OBJECTIVE To determine the association between prescription of SGLT2 inhibitors (SGLT2is) and diabetic ketoacidosis (DKA) incidence or mortality in people with type 2 diabetes (T2D) hospitalized with COVID-19. RESEARCH DESIGN AND METHODS This... Read More about Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19.